KDM6A and cancer: This review specifically addresses the role of H3K27 demethylation in various diseases, including cancer, inflammatory diseases and viral and bacterial infections, and the therapeutic potential of inhibiting this demethylation, focusing on the small-molecule KDM6A/B inhibitor GSK-J4.